KOPS - Das Institutionelle Repositorium der Universität Konstanz

Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma

Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma

Zitieren

Dateien zu dieser Ressource

Dateien Größe Format Anzeige

Zu diesem Dokument gibt es keine Dateien.

LIEBAU, Christian, Axel W. A. BALTZER, Sebastian SCHMIDT, Christian ROESEL, Christiaan KARREMAN, Johannes Bernd PRISACK, Hans BOJAR, Harry MERK, 2002. Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma. In: Anticancer Research. 22(2A), pp. 931-936. ISSN 0250-7005. eISSN 1791-7530

@article{Liebau2002Inter-38815, title={Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma}, year={2002}, number={2A}, volume={22}, issn={0250-7005}, journal={Anticancer Research}, pages={931--936}, author={Liebau, Christian and Baltzer, Axel W. A. and Schmidt, Sebastian and Roesel, Christian and Karreman, Christiaan and Prisack, Johannes Bernd and Bojar, Hans and Merk, Harry} }

Baltzer, Axel W. A. Schmidt, Sebastian Bojar, Hans Schmidt, Sebastian Roesel, Christian Merk, Harry Bojar, Hans Karreman, Christiaan Prisack, Johannes Bernd Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma Karreman, Christiaan eng Merk, Harry 2017-05-09T11:14:33Z PURPOSE: In this study we evaluated the ability of inducing activation of the enzyme indoleamine 2,3-dioxygenase (IDO) for the development of a new adjuvant therapy of osteosarcomas. The pathway that has described in the literature states that IDO activity is elevated by IFN-gamma. This mechanism is important because the increased IDO activation induces an intracellular degradation of the essential amino acid tryptophan and thereby activates apoptosis in human osteosarcoma cells.<br />MATERIALS AND METHODS: Four different well-established human osteosarcoma cell lines (MNNG/HOS, KHOS-240, HOS and MG-63) were investigated in vitro. Several cytokines were tested for their ability to induce IDO activity. However special emphasis was placed to evaluate the synergistic effects of Interleukin-12 (IL-12) in combination with Interleukin-18 (IL-18). In the first series of experiments IDO induction was investigated by direct application of the cytokines IFN-gamma, TNF-alpha, IL-12 and IL-18 in different concentrations. Secondly, the increase of IDO expression from osteosarcoma cell lines was analysed in the presence of activated lymphocytes with or without cytokine application.<br />RESULTS: Our results demonstrated that the combined application of IL-12 and IL-18 enhanced IDO activity in the human osteosarcoma cell lines HOS and MG-63, in the presence of activated lymphocytes. In the absence of activated lymphocytes, no significant enhancement could be detected. In all our experiments the increase in IDO expression was only partly inhibited by blocking INF-gamma.<br />CONCLUSION: The presented study demonstrates that IL-12 and IL-18, or even more a combined application of both cytokines, induce IDO expression besides the known pathway via IFN-gamma. These mechanisms have been shown herein for the first time in human osteosacoma cell lines. Since IDO expression could still be shown after complete blocking of IFN-gamma, we conclude that at least a second pathway is responsible for inducing IDO activity. This is in contrast to the present knowledge about IDO activation. Roesel, Christian 2002 Prisack, Johannes Bernd Liebau, Christian Baltzer, Axel W. A. Liebau, Christian 2017-05-09T11:14:33Z

Das Dokument erscheint in:

KOPS Suche


Stöbern

Mein Benutzerkonto